scholarly journals A Comparison of the Factor Analysis on Smoking Cessation Success between Inpatient Smoking Cessation Program and Residential Smoking Cessation Program

2021 ◽  
Vol 21 (3) ◽  
pp. 83-91
Author(s):  
Ga-Hee Lee ◽  
Keun-Mi Lee ◽  
Seung-Pil Jung
Keyword(s):  
Smoking Cessation ◽  
Smoking Cessation Program ◽  
Success Factor ◽  
Program Participation ◽  
University Hospitals ◽  
Quit Smoking ◽  
Urine Cotinine ◽  
System P ◽  
Nicotine Dependency ◽  
The University

Background: Since 2015, Smoking cessation program have been provided by the local smoking cessation support center in Korea. This program consisted of a 5-days of residential smoking cessation program and an inpatient program. This article is to assist smokers to quit smoking by analyzing and comparing the success factor in smoking cessation from the two different programs.Methods: This study was conducted with a total of 996 participants from the residential smoking cessation program and the inpatient program, from January 2018 to December 2020 at the University Hospitals. Based on the registration card information, we did a retrospective research. Success defines that the smoking cessation continued after 6 months of program participation when it is confirmed by urine cotinine test or phone consultation. The outcome of this study was performed by cross-tabulation analysis and regression analysis.Results: The findings show that the expected value of success in smoking cessation is higher as the subject is older in their age (P<0.05 in 60s or older), and more frequent consultations (P<0.01) in both programs. The nicotine dependency (P<0.01), social security system (P<0.01), and drinking experience (P=0.01) showed a meaningful correlation to success in smoking cessation in the residential program.Conclusions: It is required to improve the smoking cessation program to active intervention with frequent consultations when providing these two programs.

scholarly journals Successful Smoking Cessation in COPD: Association with Comorbidities and Mortality

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
H. Kupiainen ◽  
V. L. Kinnula ◽  
A. Lindqvist ◽  
D. S. Postma ◽  
H. M. Boezen ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Alcohol Abuse ◽  
Success Rates ◽  
University Hospitals ◽  
Quit Smoking ◽  
Copd Patients ◽  
Nicotine Dependency ◽  
Psychiatric Conditions ◽  
Enrollment Data ◽  
First Time

Smoking cessation is the cornerstone of COPD management, but difficult to achieve in clinical practice. The effect of comorbidities on smoking cessation and risk factors for mortality were studied in a cohort of 739 COPD patients recruited in two Finnish University Hospitals. The diagnosis of COPD was done for the first time on average 5.5 years prior to the enrollment. Data from the medical records and followup questionnaires (years 0, 1, 2, and 4) have been analyzed. The patients’ lung function varied greatly; mean FEV158% of predicted. A total of 60.2% of men and 55.6% of women had been able to quit smoking. Alcohol abuse (OR 2.1, 95% CI 1.4–3.3) and psychiatric conditions (OR 1.8, 95% CI 1.2–2.7) were strongly related to low success rates of quitting. Among current smokers high nicotine dependency was again explained by alcohol abuse and psychiatric conditions. Non-quitters were younger than quitters, but their mortality rates remained significantly higher even when the model was adjusted for impairment of lung functions and comorbidities. In conclusion, co-existing addiction and psychiatric diseases significantly decreased the success rates in smoking cessation and increased mortality among the patients.

scholarly journals Effects of smoking cessation on biological monitoring markers in urine

2020 ◽  
Vol 42 (1) ◽  
Author(s):  
Yuya Kawasaki ◽  
Yun-Shan Li ◽  
Yuko Ootsuyama ◽  
Kazuhiko Nagata ◽  
Hiroshi Yamato ◽  
...  
Keyword(s):  
Dna Damage ◽  
Smoking Cessation ◽  
Tobacco Smoke ◽  
Smoking Status ◽  
Smoking Cessation Program ◽  
Tobacco Smoke Exposure ◽  
Urinary Cotinine ◽  
Quit Smoking ◽  
Urinary Levels ◽  
Quitting Smoking

Abstract Introduction Urinary nicotine and cotinine levels are often measured as biomarkers for tobacco smoke exposure. However, these biomarkers are not appropriate to evaluate the effects of quitting smoking for several days, because of their short half-lives. In this study, we focused on the changes in the urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels of 55 patients in a smoking cessation program, because of the long half-life. At the same time, urinary 7-methylguanine (m7Gua) and 8-hydroxy-2′-deoxyguanosine (8-OHdG), as DNA damage markers of cigarette smoking, were also measured. Results In the subjects who completed the quit-smoking program (18 subjects out of 55), the urinary nicotine and cotinine levels decreased to 1.7 and 0.2% at 8 weeks after the first visit to the clinic. By contrast, the NNAL levels decreased to 12.3% at 8 weeks after quitting smoking. During the same period, the urinary m7Gua levels significantly decreased, from 27.32 μg/mg creatinine to 14.17 μg/mg creatinine by the elimination of subjects who showed increased levels of NNAL during the smoking cessation program. The 8-OHdG levels were also reduced within the same period, but were not significantly different. From the all data analysis, the urinary levels of cotinine and NNAL positively correlated with the level of m7Gua. Conclusions NNAL may be an appropriate exposure marker for evaluating the smoking status of patients in a smoking cessation program. The urinary cotinine and NNAL levels positively correlated with the m7Gua levels.

scholarly journals An evaluation study of a gender-specific smoking cessation program to help Hong Kong Chinese women quit smoking

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Ho Cheung William Li ◽  
Sophia Siu Chee Chan ◽  
Zoe Siu Fung Wan ◽  
Man Ping Wang ◽  
Tai Hing Lam
Keyword(s):  
Smoking Cessation ◽  
Hong Kong ◽  
Chinese Women ◽  
Evaluation Study ◽  
Smoking Cessation Program ◽  
Hong Kong Chinese ◽  
Quit Smoking ◽  
Gender Specific

scholarly journals Counseling of Patients with Severe Psychiatric Conditions and Referral to Smoking Cessations Programs

2021 ◽  
Vol 2 (3) ◽  
pp. 164-166
Author(s):  
Mariwan Husni ◽  
Mazin Burhan ◽  
Mohamed Mazin
Keyword(s):  
Mental Illness ◽  
Smoking Cessation ◽  
General Population ◽  
Smoking Status ◽  
Psychiatric Rehabilitation ◽  
Smoking Cessation Program ◽  
Chronic Mental Illness ◽  
Quit Smoking ◽  
Number Of Patients ◽  
Clinical Records

Background: Cigarette smoking and Nicotine dependence are highly prevalent in patients with severe and chronic mental illness. Psychiatric patients consume more cigarettes than general population. Smokers with chronic mental illness can quit smoking with appropriate intervention by smoking cessations programs. These patients can benefit from pharmacotherapy, but consideration should be given for possible interaction with patients’ psychiatric medications. Tobacco use and dependence need to be formally documents on electronic medical records and be offered a referral to smoking cessations programs. Method: All patients in a community rehabilitation service ward in Northwest London were interviewed to identify the type, quantity, and duration of their tobacco. Their electronic clinical records were reviewed to confirm their age, ICD 10 Primary Diagnosis, ICD10 Tobacco dependence diagnosis, medications they take, record of ECG tests and presence of cardiopulmonary problems. Then their records were checked if they were given advice regarding their smoking habit, desire to quit smoking and agreement to be referred to a smoking cessation program. Results and Discussion: Half of the total number of patients in the community psychiatric rehabilitation were cigarette smokers. Majority of the smokers had history of polysubstance abuse. Recording of current smoking status were not regularly update. Patients who had recorded status of being a smoker were all referred to a smoking cessation program and majority had counseling by the healthcare professionals in their unit. Attending the smoking cessation program in those patients have as good outcomes as general population. Conclusions: A substantial number of patients in psychiatric rehabilitation units smoke cigarettes. If their smoking status is accurately documented, they would be referred to a formal smoking cessation program.

scholarly journals A smoking cessation program as a resource for bladder cancer patients

2012 ◽  
Vol 6 (5) ◽  
Author(s):  
Daniel Vilensky ◽  
Nathan Lawrentschuk ◽  
Karen Hersey ◽  
Neil E. Fleshner
Keyword(s):  
Bladder Cancer ◽  
Smoking Cessation ◽  
Cost Effective ◽  
Smoking Cessation Program ◽  
Cross Sectional ◽  
Quit Smoking ◽  
Patients At Risk ◽  
Effective Program ◽  
Managing Stress

Background: Continued tobacco use following a bladder cancer(CaB) diagnosis puts patients at risk for other tobacco-associateddiseases and has also been associated with heightened risks oftreatment-related complications, tumour recurrence, morbidity andmortality. Our aim was to determine if patients with CaB who continueto smoke warrant a smoking cessation program as a resourcefor improving their prognosis and long-term health.Methods: A cross-sectional quantitative questionnaire-based studywas performed between January and April 2009. We surveyedpatients with a pathologically confirmed diagnosis of CaB duringtheir cystoscopy appointments at a single cancer centre.Results: One hundred patients completed the survey with 72% ofthem admitting to smoking in their lifetime. A third of respondentssmoked at the time of their diagnosis; 76% of patients who hadbeen active smokers at the time of their diagnosis (n = 33) reportedsmoking at some point thereafter and 58% continued to smoke. Among continued smokers, they were classified in the following categories: 26% were in “precontemplation,” 5% in “contemplation,”16% in “preparation,” and 53% in “action;” 37% of patientswho continued to smoke were interested in a hospital-based smokingcessation program. Overall, 70% reported smoking as a risk factor for a poor CaB prognosis. The two most common barriersto quitting were “trouble managing stress and mood” and “fear ofgaining weight.”Conclusion: Based on the data from our centre, patients with CaBwho continue to smoke after their diagnosis warrant a smoking cessationprogram as a resource for improving prognosis and long-term health. Further research should focus on establishing an efficacious and cost-effective program that provides these patients with theresources they need to quit smoking.

Analyzing the Adherence of a Mobile App in a Smoke-Quitting Program (Preprint)

2020 ◽  
Author(s):  
Marc Pifarre ◽  
Jordi Vilaplana ◽  
Francesc Solsona ◽  
Francesc Abella ◽  
Rui Alves ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Conventional Treatment ◽  
Mobile Apps ◽  
Mobile App ◽  
Smoking Cessation Program ◽  
Quit Smoking ◽  
The Difference

BACKGROUND Many mobile apps have been made to quit smoking. Many do not have the support of specialists, and often are apps for self-guidance. There is no record of any study looking at the apps' adherence to patient treatments from hospitals, and therefore it is not known for sure if they serve to increase the adherence of treatments. OBJECTIVE Analyzing and evaluating the adherence of using a mobile app (TControl) on a smoking cessation program. METHODS TControl, an app to follow up and assist smoke-free patients. 197 patients to measure the effectiveness of the app for decreasing the number of relapses were analysed. RESULTS Actually, the difference between those using TControl is the number of relapses (7.7%), which is much lower than among those not using it (33.9%), and which could retain considerably more patients on the program than the conventional treatment. CONCLUSIONS TControl increased adherence in a smoke-quitting program. However, no correlation between adherence and success was found.

scholarly journals Influence of Dental Pain and Tooth Sensitivity on the Intention to Quit Smoking among Schoolchildren

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Muhammad Nazir ◽  
Hassan AlAbdullah ◽  
Muhanad Alhareky ◽  
Asim Al-Ansari ◽  
Jehan Alhumaid
Keyword(s):  
Smoking Cessation ◽  
Oral Health ◽  
Dental Pain ◽  
Health Problems ◽  
Smoking Cessation Program ◽  
Intention To Quit ◽  
Tobacco Prevention ◽  
Tooth Sensitivity ◽  
Quit Smoking ◽  
Quitting Smoking

Objective. To evaluate the association between oral health problems and sociodemographic factors with the intention to quit smoking and join the tobacco cessation program among schoolchildren. Materials and Methods. This cross-sectional study included a sample of 10–12 grade male students from public high schools in different cities of the Eastern province of Saudi Arabia. Schoolchildren responded to a pilot-tested questionnaire about self-reported oral health problems and the intention to quit smoking. Bivariate and multivariate logistic regression analyses were performed. Results. Out of 587 schoolchildren, 199 were smokers with a smoking prevalence of 33.9%. Significantly higher proportions of smokers than nonsmokers had tooth sensitivity (P = 0.029) and dryness of the mouth (P = 0.001). Most smokers (75.9%) had a family history of smoking, and 51.8% started smoking within the last two years. Tooth sensitivity (56.3%), dental cavities (52.8%), and dental pain (44.7%) were highly prevalent among smokers. About one-third of smokers expressed their intention to quit smoking (38.2%) and join a smoking cessation program (33.7%). Tooth sensitivity (OR = 3.7, P = 0.004) and dental pain (OR = 2.84, P = 0.014) were significantly associated with quitting smoking. In addition, smokers with tooth sensitivity (OR = 3.22, P = 0.007) had higher odds of joining a smoking cessation program than those without tooth sensitivity. The smokers who started smoking within the last two years (OR = 3.97, P = 0.002) were more likely to quit smoking than those who initiated smoking for more than two years. Conclusion. Oral health problems were highly prevalent among smokers. Tooth sensitivity was significantly associated with quitting smoking and joining a cessation program in children. The awareness about the adverse effects of smoking on oral health should be part of regional, national, and global tobacco prevention policies and programs.

scholarly journals Effectiveness of National Residential Smoking Cessation Program

2021 ◽  
Vol 18 (18) ◽  
pp. 9901
Author(s):  
Mi-Jeong Park ◽  
Young-Gyun Seo ◽  
Hye-Mi Noh ◽  
Yeol Kim ◽  
Jong Lull Yoon ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Combination Therapy ◽  
Nicotine Dependence ◽  
Self Efficacy ◽  
Therapy Group ◽  
Smoking Cessation Program ◽  
Short Term ◽  
Factors Affecting ◽  
Urine Cotinine ◽  
Continuous Abstinence

We aimed to investigate the effectiveness of the Korean national five-day residential smoking cessation program and the factors affecting the long-term smoking cessation of participants. The residential smoking cessation program (2017–2018) recruited smokers with a smoking duration ≥ 20 years and who have attempted to quit smoking more than twice and/or smokers with chronic morbidities. Participants underwent an intensive intervention, including individual psychological therapy, group therapy, medical counseling, and pharmacotherapy. The 6-month continuous abstinence rate (CAR) was assessed via self-reports, the urine cotinine levels, and/or expired-air carbon monoxide levels. Logistic regression was used to analyze the adjusted odds ratio (aOR) to assess factors related to smoking cessation. Overall, 484 participants who completed the residential program and questionnaire were evaluated. The 3- and 6-month CAR were 81.82% and 63.22%, respectively. The aOR of 6-month continuous abstinence was lower among participants with severe nicotine dependence (aOR: 0.46, 95% confidence interval [CI]: 0.26–0.81) and higher among participants with combination therapy of varenicline with short-term nicotine replacement therapy (NRT) (aOR: 1.64, 95% CI: 1.07–2.51), with higher self-efficacy (aOR: 1.97, 95% CI: 1.15–3.37). The residential smoking cessation program was effective. High self-efficacy, combination therapy of varenicline with short-term NRT, and low nicotine dependence were associated with a high 6-month CAR.

scholarly journals LC-MS/MS Method in Nicotine Metabolites Quantification

2020 ◽  
Vol 71 (9) ◽  
pp. 277-284
Author(s):  
Adriana Gherbon ◽  
Mirela Frandes ◽  
Lavinia Noveanu ◽  
Marioara Nicula ◽  
Dorel Dronca ◽  
...  
Keyword(s):  
Smoking Prevention ◽  
Initial Assessment ◽  
Quit Smoking ◽  
Medical Tests ◽  
Final Assessment ◽  
Urine Cotinine ◽  
Nicotine Dependency ◽  
Smoking Addiction ◽  
Main Component ◽  
Two Stages

Nicotine is a ganglioplegic alkaloid, being the main component of tobacco. Some of the final metabolites of nicotine could be used to evaluate the nicotine dependency in humans using the Fagerstrom test. The test consists in cotinine quantitative determination, and evaluation of the correlation between cotinine from plasma and from urine. Cotinine quantification was performed using LC-MS/MS method both for blood and urine, in a private authorized laboratory for medical tests. Our study was conducted in two stages (1st year of study - initial assessment; and 6th year of study - final assessment) and included 62 apparently healthy subjects (77% females and 23% males) with an average age of 19�1.48 years at baseline, respectively 24�0.83 years at the final assessment. The prevalence of smoking increased significantly from 14.51% to 32.25% (p=0.01) (11% F and 3% M initially, respectively 25% F and 7% M final). The final assessment found that 21% became smokers after starting their university studies, 11% were permanent smokers throughout the 6th year study, and only 3.22% quit smoking. Percentage distribution on smoking addiction levels was at baseline: mild 11%, moderate 33%, severe 56%, and a final assessment: mild 15% (p=0.77), moderate 75% (p=0.01) and severe 10% (p=0.007). The results show a significant increase in the number of smoker girls compared to boys, a significant increase in the prevalence of moderately dependent smokers and a significant decrease in the prevalence of severely dependent smokers. LC-MS/MS can be used very well to evaluate the cotinine content in blood and urine, which could be used in Fagerstrom test in order to evaluate the nicotine addiction in young people and to find priority solutions for smoking prevention and quit smoking.

scholarly journals Strategies for Referring Cancer Patients in a Smoking Cessation Program

2020 ◽  
Vol 17 (17) ◽  
pp. 6089 ◽  
Author(s):  
James M. Davis ◽  
Leah C. Thomas ◽  
Jillian E. H. Dirkes ◽  
H. Scott Swartzwelder
Keyword(s):  
Smoking Cessation ◽  
Cancer Patients ◽  
Best Practice ◽  
Smoking Cessation Program ◽  
Cancer Center ◽  
Utilization Rate ◽  
Cancer Centers ◽  
Quit Smoking ◽  
Randomized Design ◽  
Practice Advisory

Most people who smoke and develop cancer are unable to quit smoking. To address this, many cancer centers have now opened smoking cessation programs specifically designed to help cancer patients to quit. An important question has now emerged—what is the most effective approach for engaging smokers within a cancer center in these smoking cessation programs? We report outcomes from a retrospective observational study comparing three referral methods—traditional referral, best practice advisory (BPA), and direct outreach—on utilization of the Duke Cancer Center Smoking Cessation Program. We found that program utilization rate was higher for direct outreach (5.4%) than traditional referral (0.8%), p < 0.001, and BPA (0.2%); p < 0.001. Program utilization was 6.4% for all methods combined. Inferring a causal relationship between referral method and program utilization was not possible because the study did not use a randomized design. Innovation is needed to generate higher utilization rates for cancer center smoking cessation programs.

Sign in / Sign up

Export Citation Format

Share Document